Original document(425 pages)  中文版
    A compound having the general formula (I) (wherein R 1 represents C1-C6 alkyl, etc., R 2 represents hydrogen, C2-C7 alkanoyl, C7-C11 arylcarbonyl, the formula R 4 -(CH 2 ) 1 -, etc., R 3 represents C6-C10 aryl, etc., X 1 , X 2 , X 3 , X 4 and X 5 each independently represents hydrogen, halogen, etc., and n represents an integer of 0 to 2), pharmacologically acceptable salts thereof or prodrugs thereof. They have excellent inhibition of platelet activation, etc. and are useful as a prophylactic or therapeutic agents for diseases related to thrombus or embolus formation.
Application Number
申请号
200480041105 Application Date
申请日
2004.11.26
Title 名称 Cyclic amine derivative with heteroaryl ring
Publication Number
公开号
1910151 Publication Date
公开日
2007.02.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D211/72;C07D409/06;C07D405/06;C07D401/06;C07D417/06;C07D413/06;C07D401/14;A61K31/445;A61K31/4535;A61K31/4525;A61K31/454;A61K31/4545;A61K31/497;A61K31/4709;A61P7/02;A61P9/10;A61P9/00
Applicant(s) Name
申请人
Sankyo Co.
Address 地址
Inventor(s) Name 发明人 Kimura Tomio;Tanaka Naoki;Sugidachi Kazuhiro;Konosu Toshiyuki
Attorney & Agent 代理人 pang lizhi li liantao
More information 更  多  信  息


 Related patents information
4-Oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation
Pyrimidines compounds
Preparation method for medicinal composition containing hydrogenated pyridine derivative as active components
Method and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
Remedies or preventives for AIDS
Pyridylpyrrole derivatives
Sulfonamide derivatives
Compositions for prevention or treatment of hepatopathy
Pyrrole derivatives, their preparation and their therapeutic uses
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.